Rankings
▼
Calendar
CRBU Q1 2023 Earnings — Caribou Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
CRBU
Caribou Biosciences, Inc.
$186M
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$4M
+31.5% YoY
Gross Profit
-$22M
-634.1% margin
Operating Income
-$31M
-888.5% margin
Net Income
-$28M
-800.8% margin
EPS (Diluted)
$-0.46
QoQ Revenue Growth
-5.1%
Cash Flow
Operating Cash Flow
-$28M
Free Cash Flow
-$30M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$347M
Total Liabilities
$69M
Stockholders' Equity
$278M
Cash & Equivalents
$53M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4M
$3M
+31.5%
Gross Profit
-$22M
-$11M
-97.2%
Operating Income
-$31M
-$21M
-49.2%
Net Income
-$28M
-$19M
-46.9%
Geographic Segments
UNITED STATES
$3M
97%
Non-US
$117,000
3%
← FY 2023
All Quarters
Q2 2023 →